<SEC-DOCUMENT>0001213900-25-056197.txt : 20250620
<SEC-HEADER>0001213900-25-056197.hdr.sgml : 20250620
<ACCEPTANCE-DATETIME>20250620161524
ACCESSION NUMBER:		0001213900-25-056197
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250620
DATE AS OF CHANGE:		20250620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pasithea Therapeutics Corp.
		CENTRAL INDEX KEY:			0001841330
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				851591963
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-271010
		FILM NUMBER:		251061536

	BUSINESS ADDRESS:	
		STREET 1:		1111 LINCOLN ROAD, SUITE 500
		CITY:			MIAMI BEACH
		STATE:			FL
		ZIP:			33139
		BUSINESS PHONE:		(702) 514-4174

	MAIL ADDRESS:	
		STREET 1:		1111 LINCOLN ROAD, SUITE 500
		CITY:			MIAMI BEACH
		STATE:			FL
		ZIP:			33139
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>ea0246250-424b5_pasithea.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(5) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-271010</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>(To Prospectus Supplement dated November 26,
2024, to Prospectus dated April 19, 2023)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><IMG SRC="image_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pasithea Therapeutics Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to $2,151,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">This prospectus supplement
amends and supplements the information in the prospectus, dated April 19, 2023, filed as a part of our registration statement on Form
S-3 (File No. 333-271010) (the &ldquo;Registration Statement&rdquo;), as supplemented by our prospectus supplement, dated November 26,
2024 (collectively, the &ldquo;Prior Prospectus&rdquo;), relating to the offering, issuance and sale by us of our common stock, par value
$0.0001 per share (&ldquo;Common Stock&rdquo;), from time to time that may be issued and sold under the at the market offering agreement
(the &ldquo;Sales Agreement&rdquo;), dated November 26, 2024, by and between us and H.C. Wainwright &amp; Co., LLC (&ldquo;Wainwright&rdquo;),
acting as sales agent or principal. This prospectus supplement should be read in conjunction with the Prior Prospectus, and is qualified
by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prior Prospectus.
This prospectus supplement is not complete without, and may only be delivered or utilized in connection with, the Prior Prospectus, and
any future amendments or supplements thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are filing this prospectus
supplement to amend the Prior Prospectus to update the maximum amount of shares we are eligible to sell under our Registration Statement
pursuant to General Instruction I.B.6 of Form S-3 (&ldquo;General Instruction I.B.6&rdquo;). As a result of these limitations, the current
public float of our Common Stock, and the terms of the Sales Agreement, we may offer and sell shares of our Common Stock having an aggregate
offering price of up to $4,227,669 from time to time through Wainwright, which includes the shares of Common Stock having an aggregate
sales price of approximately $2,075,688 that were sold pursuant to the Prior Prospectus and Sales Agreement during the twelve (12) calendar
months preceding the date of this prospectus supplement (the &ldquo;Prior Sales&rdquo;). As a result of the Prior Sales and the limitations
imposed by General Instruction I.B.6, as of the date of this prospectus supplement, we are eligible to offer and sell additional shares
of our Common Stock having an aggregate offering price of up to $2,151,981 from time to time through Wainwright pursuant to the Sales
Agreement. We are registering the offer and sale of shares of our Common Stock having an aggregate offering price of up to $2,151,000
pursuant to this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus
supplement, the aggregate market value of our outstanding Common Stock held by non-affiliates (the &ldquo;public float&rdquo;), was approximately
$12,683,007, which was calculated based on 7,331,218 shares of our outstanding Common Stock held by non-affiliates and a price of $1.73
per share, the closing price of our Common Stock on the Nasdaq Capital Market on April 25, 2025. During the twelve (12) calendar months
prior to and including the date of this prospectus supplement, we sold securities with an aggregate market value of approximately $2,075,688
pursuant to General Instruction I.B.6 and the Sales Agreement. Pursuant to General Instruction I.B.6, in no event will we sell securities
in a public primary offering with a value exceeding one-third of our public float in any 12-month calendar period so long as our public
float remains below $75.0 million. In the event that we become eligible to sell additional amounts under the Sales Agreement and in accordance
with General Instruction I.B.6, we will file another prospectus supplement prior to making such additional sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an &ldquo;emerging
growth company&rdquo; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and a &ldquo;smaller
reporting company&rdquo; as defined under Rule 405 of the Securities Act, and as such, we have elected to comply with certain reduced
public company reporting requirements. See &ldquo;Prospectus Supplement Summary&mdash;Implications of Being an Emerging Growth Company
and a Smaller Reporting Company&rdquo; on page S-2 of the Prior Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Common Stock is listed
on the Nasdaq Capital Market under the symbol &ldquo;KTTA.&rdquo; On June 18, 2025, the last reported sale price of our Common Stock on
the Nasdaq Capital Market was $0.7746 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in the offered
securities involves a high degree of risk. Before buying any shares, you should read the discussion of material risks of investing in
our Common Stock in &ldquo;Risk Factors&rdquo; beginning on page S-4 of the Prior Prospectus, and in the risks discussed under similar
headings in the documents incorporated by reference in this prospectus supplement and the Prior Prospectus, as they may be amended, updated
or modified periodically in our reports filed with the Securities and Exchange Commission.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NEITHER THE SECURITIES
AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY
OR ACCURACY OF THIS PROSPECTUS SUPPLEMENT AND THE ACCOMPANYING PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>H.C. Wainwright &amp; Co.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus supplement is June
20, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% 4P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HK
M"TS5]1U3^U(FTR2RDMV*6[S9VR'!P>GTZ>M<8;+XCDG,\N<\XECQ^%;QHW;3
M:0KGJ%%<MX77Q-:65Z^NYG91N@3<I=B <C(]>*T_#NJ7>KZ4+J]L'LIM[+Y3
MYY [\\U$J;C?6]@N:U%%%9C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KP/XN>(=3E\63:0+B6&QMHT*Q(Q42%ADLV.OH/I7OE<OXJ\!:+XN>.:^26*
MZC7:L\#;6*^AR""*TI24978'G7P:\0ZG)KD^C33RSV36YE19&+>4RD#@GH#G
MI7JVM>*-$\/20QZMJ$5J\P)C#@G<!C/0>XJKX6\%Z1X1AE73HW::;'FSS-N=
M@.@]A["O(OC1??:/&<-J#Q:VB@_5B3_+%:6C4J:;"/9-'\6Z#X@N9+;2M2CN
MIHTWLJ*PPN<9Y'K6U7COP,LA_P 3G4".<QP*?P+'^8KV*LJD5&5D,\P^,'B;
M4=$CTJWTN^EM)IFD>1HB 2H  'YG]*Q?A5X@\1:[XMDCO]6NKFU@MFD>.1AM
M)) ';W-9'QFO/M'C>.W'2UM$4_5B6_EBN@^!EEB/6=0(ZM' I^@+'^8KHLE2
MN+J>P4445R#"BBB@ HHHH **** "BBB@ HHHH *XF/PWXE7Q=_:#:QFQ\_?L
M\QN8_P"YLZ=./UJ7Q;H'B#5=0AFTO4O)MU3:8O-:/#9Z\=?_ *U.OM!\13^$
M[2PBU;%_$V9I-[+YB\X7=UXR/KBNJFE%74EK^!+,3Q_9:]:7,VK1:C*-.^11
M'',R&/MT'!Y[^]7_  YH/B6+2[XW.K,K75L!;AI6D,;'G=D]...*Y*V\.>(]
M=N+VR:Z,ALI DJSW#,H;VZYXKK_#_AGQ'IVG:A;SZJ$,L'EVRK(SB-O[W/3T
MXKIJ-1IJ',K^GH);G)OI?BJ/7X]%.I3_ &N2/S%87;[=OKGKV]*[G6]"U^]\
M.V%G:ZKMNX<?:)-[)YW'J.>OYUQ\_@7Q/$[W[W43SQJ6\P7#;^!V)%7O!6F>
M([RXLM7;4Y/[/+$LDD[.9%&01MZ=:=1II34EIY=01W/ARQO].T6&VU.Z^TW*
MDY?).!G@9/)QZUJUP&L^%_%=YKEQ<VFL>7;N^Z(>>Z[!Z;0,<?K7>0JZ01I(
M^]U4!FQC<<<FN&I%?%=.Y2'UQ?Q0UZ\T#P@;C3[DV]W+<1Q(X ) ZG&?8&NT
MKQ_XYWP\O1M/!Y+23L/8 */YFII*\TAG(:7\4?$UA>_:+J^DOD5&"P2[0A8C
M )P,X'7 K/O_ !_XJU&=I)=;N8LGB.W;RE'T J?P!X13QAKSVUQ,\5I;Q^;,
M4^\PS@*#VSZ^U>ZVW@'PK:VOV=-"LV0C!,D>]C_P(\UTSE"#VU$>(Z)\4/%&
MCW"-+?-J%N#\T-UR2/9NH/YU[UX:\167BC18M2L20K?+)&WWHW'537B'Q0\%
MVOA74K:ZTX%+"\W 1$D^4XY(!/8CD?0UH_!/5)+?Q)>:86/DW4'FA?\ ;0]?
MR)_*IJ1C*'/$#UCQ5XKT_P ):4;V^8L[';# A^>5O0>WJ>U>&ZU\4_%&K3,8
M;S^SX/X8K48('NQY/Z55^(FOR>(/&5Y)N)M[5C;0+G@*IP3^)R?RKJOAG\-[
M36K%=<UM#);.Q%M;9P' X+-CJ,Y 'M3C"-./-(#BK7QUXIM)1)%K]Z2#G;))
MYBGZALUTM_\ %_7+[0([6/%IJ23!FNX,;73!R-IS@YQ7KUSX%\+75M]GDT*R
M"8P#'$$8?0CFOG_QQX?MO#'BJYTNTG>:%561=_WD##.TGOCUIPE"H]@.]^%?
MB;Q%X@\4S1:CJDUQ:P6S2-&RJ 6) '0?6ND^(GQ%'A0IIVGQI-JDJ;R9.4A4
M]"1W)["L'X&66+;6+\C[TD<*GZ D_P Q7%?%*">#XAZD9PV)1')&3W3: ,?B
M"*GEC*K;L!G7GCOQ1>3>;/K]XASD".3RU'T"XK1TCXH^*=)D#-J'VZ$?>CNQ
MNR/]X<BM?X9^)?"NDPS66NV4*7,LNY;V6(2+MP,*>#MQS[<UZ?-X$\(:U=6N
MJQV%LQ1Q*KVQ CEQT# <,*J<HQ=G$#9\/:M)K>@VFI364MDTZ;_)E() ['Z'
MJ/:O -0^)'BF34[M[;69HX#._E(%7"KN.!T]*]_\1WHTSPQJ=YG;Y-K(R^QV
MG'ZU\H(C2;(QDNY"_B>*BA%.[:!G3?\ "R/%O_0>G_[Y3_"L/4=2O-7OI+Z_
MN&N+F3&Z1L9.!@=/:OIJ/PUH.GZ4AFTBP;[/ -[-;H2=J\DG'M7R[-*)9)9@
M,!V9P ,8!.<5K3E&5[*P&KI/BS6]!MGMM+U-[6%WWLB!>6P!GD>@%>J_"/Q!
MKWB'4=3DU/4Y;JWMXD548* '8GG@>BG\ZZKPKX3TB'PGI276E64MQ]EC,CO
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MM[_9_@369PVUOLS1J?=OE'\Z^9]-M&O=4LK-!DSSQQ@?5@*]T^-%Z+?P5';
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M\7:C"+"$1P0P/$N.$8[LD?D/RIN[7O/I<"YXB\$Z)XJNH9]4CFDD@0H@28H
M"<]!2>'/!>@^%KRXETJ-TGF0))OF+G:#GH>E5I+BXM;CQA/;9\^)(VC[X(AJ
M2#0="BTFTO\ S!!)B.47XEP[,<<ECUR3C'O2Y6E9O3_@7 Z@NJD!F )X )ZU
MR7B#X;>&_$5RUU<6SV]TYR\UJVPN?4CD'ZXS3/$.G)/JMS?O;Q:I!# J36PF
MV2VV,MN3MDCGL>.*ZJSN(KJQ@N("3%+&KH6ZX(R,U+3@E*+ X.R^#/A:VE5Y
M_MMV!U2:;"GZA0/YUTFO>#-&\26UG;ZA#(8;,$0I%(4"Y ';V%;]%2YR;O<9
MR^@?#_P_X:U(ZAIMO*MQY9CW/,SX!QG@_2NHHHJ6V]6!A^(_"6E>*X[>/58Y
M72W8M&$E*<D8.<=:IZ#\/O#_ (;U/^T-.MYEN AC#/,S  XSP?I7444^9VM<
M K#U_P (:'XF4?VG8))*HPLR_+(O_ AS^!K<HI)M:H#S4_!+PX9,B\U()_=\
MU?Y[:Z?0/ GA[PVXEL+!3<#_ )>)CYD@^A/3\,5T=%4ZDGHV 5GZQH>F:_9F
MTU2SCN8<Y <<J?4'J#]*T**A.P'F\OP4\-/-O2YU&-"<[!,I ^A*YK<M/AMX
M8LM+N;&&Q.+E/+EF:0F5E] W;\,5UE%6ZDGU X_2_ACX8T?5+?4;2UF%Q;MO
MC+SLP!QC.#]:["BBI<F]P"BBBD!BV/ANSTA-2?3VEBEO<LSEMVQL'!'T)S7C
MTTFH13R1MJ=TQ5B"WF-S[]:**]+!R<G*^I$CT'X?6T]QH]_]KO9KB&<^7Y;L
M3LX(."3WS^E=3HFB6>@:>+*R#^5N+_.V22:**Y:\GSR70I;&C1117.,H:QHN
MGZ]I[6.IVXGMF8,4+$9(Z=#6-8?#OPKIE_!?6FDI'<P/OC?S'.UO7DT44U)I
M63 Z@C(Q5:VL+:TL5LH(PENJE0F3T/7^=%%%P(VTFR;3HM/, ^RP[-D>3QM(
M*_D0*CO]"T_4[E+BZA9ID38'61D.W.<<$=Z**:E):I@2+I-DMM;6_E%H[:02
MQ!G9BK D@Y)R>IIL^C6%R;PRP _;%5;@!B!(!TS@_A111S2[@3W%C;72P":(
M,()%EBP<;6'0C%+!9P6T]Q-%'MDN&#RG/WB!C/Y"BBE=[ 5=0T/3]3N$GNH6
M:5%**ZR,A )SC@BG'1K!M+_LUX/,M?[CL6/7.<DYSGWHHI\TMK@&FZ-8Z3YA
MM(2KRXWN[EV;'3)))JQ'9V\5[->)&!/,JK(^>H7./YFBBDY-ZM@)%96\-S<W
M$<8$MR5,K9SNP,#]*SXO"VC072W$=D 4;>B%V**WJ$S@'\***:G);,"2_P##
MVEZG<?:+JVW2E0KE79=Z^C8(W#ZUI(BQQJB*%10 J@8 'I112<FU9L!U%%%(
? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
